nanoscience enables ultrasensitive detection of alzheimer s biomarker
Download
Skip this Video
Download Presentation
Nanoscience enables ultrasensitive detection of Alzheimer\'s biomarker

Loading in 2 Seconds...

play fullscreen
1 / 6

Nanoscience enables ultrasensitive detection of Alzheimer's biomarker - PowerPoint PPT Presentation


  • 101 Views
  • Uploaded on

Christine D. Keating . PNAS 2005, 102, No. 7, 2263 –2264 Jwa-Min Nam, Shad Thaxton, Chad A. Mirkin. Science 2003, 301, 1884-1886. Nanoscience enables ultrasensitive detection of Alzheimer\'s biomarker. Student: Xu Zhang. Alzheimer\'s disease.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Nanoscience enables ultrasensitive detection of Alzheimer's biomarker' - sana


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
nanoscience enables ultrasensitive detection of alzheimer s biomarker

Christine D. Keating . PNAS 2005, 102, No. 7, 2263 –2264

Jwa-Min Nam, Shad Thaxton, Chad A. Mirkin. Science 2003, 301, 1884-1886

Nanoscience enables ultrasensitive detection of Alzheimer\'s biomarker

Student: Xu Zhang

alzheimer s disease
Alzheimer\'s disease
  • Alzheimer\'s disease (AD), which afflicts an estimated 16 million people worldwide, is a neurodegenerative dementia characterized by memory loss and cognitive impairment.
  • Symptoms begin with mild cognitive impairment.
  • It’s tough to distinguish from other more benign forms of age-related dementia.
alzheimer s disease1
Alzheimer\'s disease
  • Smaller, soluble oligomers of peptides, referred to as amyloid--derived diffusible ligands (ADDLs), have recently been hypothesized as the causative agent in AD-related memory loss.
  • Support for the role of ADDLs comes from their neurotoxicity, and mouse studies that indicate a reversal of memory loss upon injection of amyloid- antibodies
  • This paper presented an ultrasensitive, nanoparticle-based protein detection strategy termed bio-barcode amplification (BCA) to detect ADDL concentration in the cerebrospinal fluid (CSF).
bio barcode amplification bca strategy
Bio-barcode Amplification (BCA) Strategy
  • CSF is first exposed to monoclonal anti-ADDL antibodies bound to magnetic microparticles.
  • After ADDL binding, the microparticles are separated with a magnetic field and washed before addition of secondary antibodies bound to DNA:Au nanoparticle conjugates.
  • Unreacted Au nanoparticle conjugates are removed after magnetic separation, then elevated temperature release the barcode DNA for analysis.
  • Each Au nanosphere carries hundreds of identical barcode DNA strands, providing substantial amplification.
scanometric dna detection
Scanometric DNA detection
  • The probe strands are arrayed on a solid support and the detection strand is bound to an Au nanosphere.
  • The selectively assembled Au nanospheres then act as nucleation sites for Ag deposition upon the chemical reduction of Ag+ from solution.
  • The resulting Ag deposits can be quantified by a simple desktop scanner such as is used to scan documents for computer manipulation (hence scanometric)
advantages
Advantages
  • Ultrasentivity with built-in signal amplification mechanism. 30 attomolar (30 x 10-18 M) for protein targets, useful for early diagnosis.
  • Can also be applicable for DNA or RNA diagnosis, or simultaneously multiple monitoring.
  • Rapid diagnosis due to performing the BCA assay in homogeneous suspension.
  • It marks one of the first real applications of nanotechnology, while the vast majority of the countless publications on nanoparticle-based diagnostics are in the proof-of-principle stage.
ad